Sutro Biopharma, Inc. financial data

Symbol
STRO on Nasdaq
Location
111 Oyster Point Blvd., South San Francisco, CA
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Nov 6, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 254 % -32.1%
Debt-to-equity -1.27K % -599%
Return On Equity 862 %
Return On Assets -73.4 % -169%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 85.1M shares +3.25%
Common Stock, Shares, Outstanding 85.1M shares +3.29%
Entity Public Float 238M USD -14.6%
Common Stock, Value, Issued 85K USD +3.66%
Weighted Average Number of Shares Outstanding, Basic 84.9M shares +3.45%
Weighted Average Number of Shares Outstanding, Diluted 84.9M shares +3.45%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 106M USD -34.4%
Research and Development Expense 201M USD -14.5%
General and Administrative Expense 41.4M USD -26.4%
Operating Income (Loss) -186M USD -42.7%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -56.9M USD -16.5%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -217M USD -74.9%
Earnings Per Share, Basic -2 USD/shares -133%
Earnings Per Share, Diluted -2 USD/shares -133%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 65.9M USD -62.2%
Marketable Securities, Current 102M USD -52.4%
Accounts Receivable, after Allowance for Credit Loss, Current 3.92M USD -41.1%
Assets, Current 182M USD -55.1%
Property, Plant and Equipment, Net 13.3M USD -29.7%
Operating Lease, Right-of-Use Asset 13.3M USD -29.9%
Other Assets, Noncurrent 0 USD -100%
Assets 210M USD -53.6%
Accounts Payable, Current 7.03M USD +13.2%
Accrued Liabilities, Current 13.2M USD +0.54%
Contract with Customer, Liability, Current 8.98M USD -87.6%
Liabilities, Current 71.9M USD -45.2%
Contract with Customer, Liability, Noncurrent 3.76M USD -79.1%
Operating Lease, Liability, Noncurrent 9.7M USD -45.1%
Other Liabilities, Noncurrent 1.69M USD 0%
Liabilities 297M USD -12.8%
Accumulated Other Comprehensive Income (Loss), Net of Tax 33K USD -68.9%
Retained Earnings (Accumulated Deficit) -931M USD -30.3%
Stockholders' Equity Attributable to Parent -87.3M USD -178%
Liabilities and Equity 210M USD -53.6%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -67.9M USD -4.85%
Net Cash Provided by (Used in) Financing Activities 66K USD
Net Cash Provided by (Used in) Investing Activities -16.3M USD -125%
Common Stock, Shares Authorized 300M shares 0%
Common Stock, Shares, Issued 85.1M shares +3.29%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -84.1M USD -1968%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 66.8M USD -61.9%
Interest Paid, Excluding Capitalized Interest, Operating Activities 0 USD -100%
Deferred Tax Assets, Valuation Allowance 228M USD +35.9%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure
Deferred Tax Assets, Gross 232M USD +28.2%
Operating Lease, Liability 17.7M USD -29%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -217M USD -75.1%
Lessee, Operating Lease, Liability, to be Paid 19.7M USD -32.4%
Property, Plant and Equipment, Gross 66.8M USD +4.24%
Operating Lease, Liability, Current 7.96M USD +10.5%
Lessee, Operating Lease, Liability, to be Paid, Year Two 8.29M USD -7.84%
Lessee, Operating Lease, Liability, to be Paid, Year One 8.99M USD -5.65%
Operating Lease, Weighted Average Discount Rate, Percent 0.11 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 2.05M USD -52.4%
Lessee, Operating Lease, Liability, to be Paid, Year Three 8.29M USD -7.84%
Deferred Tax Assets, Operating Loss Carryforwards 39.7M USD +6.53%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 12.1M USD +38.1%
Lessee, Operating Lease, Liability, to be Paid, Year Four 8.29M USD -7.84%
Operating Lease, Payments 2.3M USD 0%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 1.9M USD +7.89%
Deferred Tax Assets, Net of Valuation Allowance 3.82M USD -70.8%
Share-based Payment Arrangement, Expense 18.3M USD -26.9%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%